thiocolchicoside 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definition	Drug id	CAS RN
	4731	602-41-5

Description:

Molecule

Description

Molfile Inchi Smiles

Synonyms:

thiocolchicoside
thiocholshikoside
coltramyl
muscoril

used in combination with glafenine and meprobamate to tranquilize patients undergoing hysterosalpingography; structure

Molecular weight: 563.62
Formula: C27H33NO10S
CLOGP: -0.89
LIPINSKI: 2
HAC: 11
HDO: 5
TPSA: 164.01
ALOGS: -3.21
ROTB: 7

Drug dosage:

None

ADMET properties:

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Poisoning deliberate	65.34	42.94	18	781	7826	34948306

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Poisoning deliberate	53.83	39.20	19	1771	18809	79723789
Palatal oedema	47.47	39.20	10	1780	1421	79741177
Melaena	46.29	39.20	24	1766	60866	79681732
Urticaria	46.16	39.20	36	1754	185165	79557433
Erythema	42.27	39.20	37	1753	223253	79519345
Hepatocellular injury	39.76	39.20	20	1770	47573	79695025

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
ATC	M03BX05	MUSCULO-SKELETAL SYSTEM MUSCLE RELAXANTS MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS Other centrally acting agents
ATC	M03BX55	MUSCULO-SKELETAL SYSTEM MUSCLE RELAXANTS MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS Other centrally acting agents

Drug Use | Suggest Off label Use Form| |View source of the data|

Disease	Relation	SNOMED_ID	DOID
Spasticity	indication	221360009

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation level	Dissociation constant	Type (acidic/basic)
pKa1	12.22	acidic
pKa2	12.23	acidic
pKa3	12.92	acidic
pKa4	13.44	acidic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

Target	Class	Pharos	UniProt	Action	Type	Activity value (-log[M])	Mechanism action	Bioact source	MoA source
GABA-A receptor alpha-1/beta-2/gamma-2	Ion channel	P14867 P18507 P47870	GBRA1_HUMAN GBRG2_HUMAN GBRB2_HUMAN	NEGATIVE MODULATOR	IC50	6.70		SCIENTIFIC LITERATURE
GABA A receptor alpha-2/beta-2/gamma-2	Ion channel	P18507 P47869 P47870	GBRG2_HUMAN GBRA2_HUMAN GBRB2_HUMAN	NEGATIVE MODULATOR	IC50	6.89		SCIENTIFIC LITERATURE
GABA A receptor alpha-1/beta-1/gamma-2	Ion channel	P14867 P18505 P18507	GBRA1_HUMAN GBRB1_HUMAN GBRG2_HUMAN	NEGATIVE MODULATOR	IC50	6.82		SCIENTIFIC LITERATURE
GABA-A receptor; anion channel	Ion channel		GBRP_RAT GBRB1_RAT GBRD_RAT GBRG2_RAT GBRA5_RAT GBRA3_RAT GBRG1_RAT GBRA2_RAT GBRA4_RAT GBRG3_RAT GBRA6_RAT GBRA1_RAT GBRB3_RAT GBRB2_RAT Q91ZM7_RAT GBRE_RAT		IC50	5.72		CHEMBL

External reference:

ID	Source
D07276	KEGG_DRUG
CHEBI:94557	CHEBI
CHEMBL1705373	ChEMBL_ID
C004280	MESH_SUPPLEMENTAL_RECORD_UI
671	INN_ID
DB11582	DRUGBANK_ID
T1X8S697GT	UNII
38085	RXNORM
005350	NDDF
1173015002	SNOMEDCT_US
735241007	SNOMEDCT_US
C0076456	UMLSCUI
9915886	PUBCHEM_CID

Pharmaceutical products:

None